Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/2012
04/17/2012CA2529351C Use of prostaglandin i for enhancing the effect of a renin-angiotensin system inhibitor on a renal disease
04/17/2012CA2511595C Optically active dihydropyridine derivative
04/17/2012CA2493843C Azolidinone-vinyl fused-benzene derivatives
04/17/2012CA2474163C Novel elongase gene and method for producing polyunsaturated fatty acids
04/17/2012CA2474104C N-oxides of n-phenyl-2-pyrimidine-amine derivatives
04/17/2012CA2407806C Use of heparin or nonanticoagulant heparin for inhibiting apoptosis arising from ischemia perfusion injury
04/17/2012CA2402894C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv and method
04/17/2012CA2371625C Polyamines and their use in therapy
04/17/2012CA2363958C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
04/17/2012CA2347928C Cell surface molecule-induced macrophage activation
04/12/2012WO2012048125A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
04/12/2012WO2012048059A2 Bepotastine compositions
04/12/2012WO2012047826A2 Methods of use of small molecule modulators of hepatocyte growth factor (scatter factor) activity
04/12/2012WO2012047629A2 Selective removal of age-modified cells for treatment of ather0sclerosis
04/12/2012WO2012046132A1 Quinazoline compounds as sodium channel blockers
04/12/2012WO2012046062A1 Use of prodrugs to avoid gi mediated adverse events
04/12/2012WO2012045286A1 Recombinant vector and fibroin membrane modified by transgenic bone stromal cell, and application thereof
04/12/2012WO2012045285A1 Pharmaceutical composition and application thereof
04/12/2012WO2012045210A1 Pharmaceutical composition for treating septic shock and its use
04/12/2012WO2012024584A3 Oxysterol compounds
04/12/2012WO2012024581A3 Oxysterol compounds
04/12/2012WO2012010641A3 Pharmaceutical composition for increasing cellular hypoxic tolerance
04/12/2012WO2012007846A3 A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
04/12/2012WO2012003370A3 Functional vascularization with biocompatible polysaccharide-based hydrogels
04/12/2012WO2011135581A3 Pharmaceutical compositions of dronedarone
04/12/2012WO2011103330A3 Novel phosphorylation of cardiac troponin i as a monitor for cardiac injury
04/12/2012WO2011043788A8 Daptomycin for multiple sclerosis
04/12/2012US20120088911 Novel carboxylic acid derivatives, their preparation and use
04/12/2012US20120088896 Drug for inhibiting lectin-like oxidized ldl receptor and drug for preventing arteriosclerosis
04/12/2012US20120088839 Composition for regulating cellular senescence comprising [n-2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide
04/12/2012US20120088835 Methods and compositions for treatment for coronary and arterial aneurysmal subarachnoid hemorrhage
04/12/2012US20120088832 Anti-Adhesive Barrier Membrane Using Alginate and Hyaluronic Acid for Biomedical Applications
04/12/2012US20120088830 Satiety-inducing composition
04/12/2012US20120088827 Oxabicyclo[4.1.0]Hept-B-en-S-yl Carbamoyl Derivatives Inhibiting The Nuclear Factor-Kappa (B) - (NF-KB)
04/12/2012US20120088825 Compounds with activity at estrogen receptors
04/12/2012US20120088821 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
04/12/2012US20120088817 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
04/12/2012US20120088809 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
04/12/2012US20120088800 2-(SUBSTITUTED) (ARYLMETHYL, ARYLOXY and ARYLTHIO))-N-(SUBSTITUTED PYRIDIN-2-YL)-2-(SUBSTITUTED ARYL) COMPOUNDS AS SUBTYPE-SELECTIVE MODULATORS OF SPHINGOSINE-1-PHOSPHATE-3 (S1P3) RECEPTORS
04/12/2012US20120088799 Serotonin reuptake inhibitors
04/12/2012US20120088784 Substituted Aromatic Compounds and Pharmaceutical Uses thereof
04/12/2012US20120088783 Chroman derivatives
04/12/2012US20120088780 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/12/2012US20120088779 Heterocyclic sulfonamides
04/12/2012US20120088778 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
04/12/2012US20120088774 Active pharmaceutical ingredient adsorbed on solid support
04/12/2012US20120088771 Tissue-nonspecific alkaline phosphatase (tnap): a therapeutic target for arterial calcification
04/12/2012US20120088770 Alpha helix mimetics and methods relating thereto
04/12/2012US20120088769 Salts of arylsulfonamide ccr3 antagonists
04/12/2012US20120088762 Compounds for enzyme inhibition
04/12/2012US20120088760 Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
04/12/2012US20120088758 Five-membered heterocycles useful as serine protease inhibitors
04/12/2012US20120088753 Pyrrolopyrimidines and used as kinase inhibitors
04/12/2012US20120088751 Pharmaceutical compounds
04/12/2012US20120088747 Sulfonamide containing compounds and uses thereof
04/12/2012US20120088746 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
04/12/2012US20120088742 Acetylsalicylic acid salts
04/12/2012US20120088741 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
04/12/2012US20120088738 Inhibitors of fatty acid amide hydrolase
04/12/2012US20120088737 Novel acyl guanidine derivatives
04/12/2012US20120088736 [4-(6-HALO-7-Substituted-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL)-PHENYL]-5-CHLORO-THIOPHEN-2-YL-SULFONYLUREAS and Forms and Methods Related Thereto
04/12/2012US20120088728 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury
04/12/2012US20120088727 Rspondins as modulators of angiogenesis and vasculogenesis
04/12/2012US20120088716 Polypeptide Protracting Tags
04/12/2012US20120088715 Mutated antithrombins, a process for preparing the same and their use as drugs
04/12/2012US20120087956 Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
04/12/2012US20120087926 Chicken-derived anti-lox-1 antibody
04/12/2012US20120087925 Method for the treatment of inflammatory disorders
04/12/2012US20120087921 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
04/12/2012US20120087910 Sparc angiogenic domain and methods of use
04/12/2012US20120087896 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays
04/12/2012US20120087891 Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances
04/12/2012US20120087865 Treatment of ischemia
04/12/2012DE102010047582A1 New receptor agonists exhibiting an activity e.g. diuresis, and influencing cyclic guanosine monophosphate, are natriuretic peptide receptors A and B binders, useful for prevention and/or therapy of disease e.g. pulmonary fibrosis
04/12/2012CA2818215A1 Compositions and methods for treating ocular edema, neovascularization and related diseases
04/12/2012CA2813748A1 Bepotastine compositions
04/12/2012CA2813719A1 Methods of use of small molecule modulators of hepatocyte growth factor (scatter factor) activity
04/12/2012CA2813704A1 Quinazoline compounds as sodium channel blockers
04/12/2012CA2812795A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
04/12/2012CA2812593A1 Alpha-ketoamide derivatives useful endothelial lipase inhibitors
04/11/2012EP2439204A1 Heterocyclic compound and hematopoietic stem cell amplifier
04/11/2012EP2439200A1 Anthraquinone compounds and their uses
04/11/2012EP2439197A1 Substituted benzimidazole derivatives as melanocortin 4 receptor antagonists
04/11/2012EP2439195A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
04/11/2012EP2439193A1 Derivatives of 5,6-bisaryl-2-pyridine-carboxamide, preparation and use thereof in therapeutics as antagonists of urotensin II receptors
04/11/2012EP2438915A1 Improvement of arginase levels/activity
04/11/2012EP2438169A1 Nucleic acid modulators of glycoprotein vi
04/11/2012EP2438167A1 Therapeutic and diagnostic molecules
04/11/2012EP2438060A1 Active metabolite of a thrombin receptor antagonist
04/11/2012EP2438055A1 Dihydroindole and tetrahydroisoquinoline derivatives useful as potassium channel inhibitors
04/11/2012EP2438043A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/11/2012EP2437741A1 The use of amlexanox in the therapy of neutrophil-driven diseases
04/11/2012EP2437727A2 Peptides for transport of therapeutics and their carriers in mouse models and humans
04/11/2012EP2119718B1 Macrocyclic compound
04/11/2012EP2059508B1 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
04/11/2012EP2035022B1 Pharmaceutical use of protein molecules immunologically correlated to diphtheria toxin
04/11/2012EP1724258B1 Heteroarylphenylurea derivative
04/11/2012EP1675552B1 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
04/11/2012EP1532153B8 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
04/11/2012EP1362030B1 Novel benzoylguanidine salt
1 ... 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... 1595